lamotrigine

Generic: lamotrigine

Labeler: a-s medication solutions
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name lamotrigine
Generic Name lamotrigine
Labeler a-s medication solutions
Dosage Form TABLET
Routes
ORAL
Active Ingredients

lamotrigine 100 mg/1

Manufacturer
A-S Medication Solutions

Identifiers & Regulatory

Product NDC 50090-2130
Product ID 50090-2130_a2a8622a-6df4-4c7e-b026-fd5080a9196a
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA090170
Listing Expiration 2027-12-31
Marketing Start 2011-11-01

Pharmacologic Class

Established (EPC)
anti-epileptic agent [epc] mood stabilizer [epc]
Mechanism of Action
organic cation transporter 2 inhibitors [moa] dihydrofolate reductase inhibitors [moa]
Physiologic Effect
decreased central nervous system disorganized electrical activity [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 500902130
Hyphenated Format 50090-2130

Supplemental Identifiers

RxCUI
198427 198428 282401
UNII
U3H27498KS
NUI
N0000175753 N0000008486 N0000175751 N0000187061 N0000000191

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name lamotrigine (source: ndc)
Generic Name lamotrigine (source: ndc)
Application Number ANDA090170 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 100 mg/1
source: ndc
Packaging
  • 30 TABLET in 1 BOTTLE (50090-2130-0)
  • 60 TABLET in 1 BOTTLE (50090-2130-1)
  • 90 TABLET in 1 BOTTLE (50090-2130-2)
source: ndc

Packages (3)

50090-2130-0 30 TABLET in 1 BOTTLE (50090-2130-0) 50090-2130-1 60 TABLET in 1 BOTTLE (50090-2130-1) 50090-2130-2 90 TABLET in 1 BOTTLE (50090-2130-2)

Ingredients (1)

lamotrigine (100 mg/1)

Linked Drug Pages (1)

Lamotrigine ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "a2a8622a-6df4-4c7e-b026-fd5080a9196a", "openfda": {"nui": ["N0000175753", "N0000008486", "N0000175751", "N0000187061", "N0000000191"], "unii": ["U3H27498KS"], "rxcui": ["198427", "198428", "282401"], "spl_set_id": ["6139a858-700c-4eb9-9f84-99d280bde326"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_epc": ["Anti-epileptic Agent [EPC]", "Mood Stabilizer [EPC]"], "pharm_class_moa": ["Organic Cation Transporter 2 Inhibitors [MoA]", "Dihydrofolate Reductase Inhibitors [MoA]"], "manufacturer_name": ["A-S Medication Solutions"]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE (50090-2130-0)", "package_ndc": "50090-2130-0", "marketing_start_date": "20151015"}, {"sample": false, "description": "60 TABLET in 1 BOTTLE (50090-2130-1)", "package_ndc": "50090-2130-1", "marketing_start_date": "20151015"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (50090-2130-2)", "package_ndc": "50090-2130-2", "marketing_start_date": "20180315"}], "brand_name": "Lamotrigine", "product_id": "50090-2130_a2a8622a-6df4-4c7e-b026-fd5080a9196a", "dosage_form": "TABLET", "pharm_class": ["Anti-epileptic Agent [EPC]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]", "Dihydrofolate Reductase Inhibitors [MoA]", "Mood Stabilizer [EPC]", "Organic Cation Transporter 2 Inhibitors [MoA]"], "product_ndc": "50090-2130", "generic_name": "Lamotrigine", "labeler_name": "A-S Medication Solutions", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Lamotrigine", "active_ingredients": [{"name": "LAMOTRIGINE", "strength": "100 mg/1"}], "application_number": "ANDA090170", "marketing_category": "ANDA", "marketing_start_date": "20111101", "listing_expiration_date": "20271231"}